Ratings changes for Fortress Biotech, Wilhelmina International, Reviva Pharmaceuticals, Eiger BioPharmaceuticals, OptimumBank, Cantaloupe, U.S. Energy and moreâŠText âMarketBeatâ to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More. Unsubscribe.
VIEW MY PORTFOLIO
December 26th, 2023
 Â
This is the #1 Stock to Buy for the AI Tidal Wave (ad)
Marc Chaikin warned people about NVDA before its 2023 bull run â now heâs naming his next pick or the AI tidal wave.
WARNING: Mandatory U.S. Dollar Recall to Begin on December 13th? (ad)
If you have any U.S. dollars in your bank account⊠You must see this shocking video exposing the governmentâs new plan to recall the U.S. dollar.
According to Business Insider, this recall âcould be imminent.â And if you donât prepare now, you could end up holding a bunch of worthless U.S. dollars.
Hidden In Plain SightâThe Secret To Earning More! (ad)
Hi, this is 10 time trading champion Chuck Hughes and for a long time even I was missing out on the strategy that took my account to a whole new level⊠In my new guide, âHidden Income Strategyâ, Iâll reveal exactly how you could use this unique strategy to earn moreâstarting now!
AlloVir (NASDAQ:ALVR) was downgraded by analysts at Bank of America Co. from a âbuyâ rating to an âunderperformâ rating.The current price is $0.76.
United Parcel Service (NYSE:UPS) was downgraded by analysts at Daiwa Capital Markets from an âoutperformâ rating to a âneutralâ rating. They now have a $155.00 price target on the stock. This represents a 1.8% downside from the current price of $157.91.
Foreign Affairs reports, âChina is Now in a Prewar Tempo of Political and Military Preparations.â China has one goal: take control of Taiwan, and an invasion could happen any day. Iâve identified 5 investments I believe are in immediate danger. But you can get out of them now â before itâs too late.
Dianthus Therapeutics (NASDAQ:DNTH) is now covered by analysts at Jefferies Financial Group Inc.. They set a âbuyâ rating and a $22.00 price target on the stock. This represents a 96.3% upside from the current price of $11.21.
Sign up for MarketBeat All Access to gain access to MarketBeatâs full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeatâs trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See whatâs happening in the market right now with MarketBeatâs real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeatâs free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (thatâs you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.